Arundathy N. Pandite Shattuck Labs, Inc. (STTK) insider trading activity

Arundathy N. Pandite is Chief Medical Officer of Shattuck Labs, Inc.. Currently has a direct ownership of 199,414 shares of STTK, which is worth approximately $390,851. The most recent transaction as insider was on Jan 10, 2026, when has been sold 6,851 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $32,542. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K

3.32% 3M change

4.8% 12M change

Total Value Held $390,851

Arundathy N. Pandite Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2026	SELL Payment of exercise price or tax liability	$32,542 $4.75 p/Share	6,851 Reduced 3.32%	199,414 Common Stock
Jan 25 2025	SELL Payment of exercise price or tax liability	$3,724 $1.16 p/Share	3,211 Reduced 1.53%	206,265 Common Stock
Jan 10 2025	SELL Payment of exercise price or tax liability	$8,191 $1.19 p/Share	6,884 Reduced 3.18%	209,476 Common Stock
Jan 30 2024	SELL Payment of exercise price or tax liability	$29,170 $9.99 p/Share	2,920 Reduced 1.33%	216,360 Common Stock
Jan 10 2024	SELL Payment of exercise price or tax liability	$30,138 $10.09 p/Share	2,987 Reduced 1.34%	219,280 Common Stock
Jan 10 2024	BUY Grant, award, or other acquisition	-	46,475 Added 17.29%	222,267 Common Stock
Jan 25 2023	BUY Grant, award, or other acquisition	-	37,875 Added 17.73%	175,792 Common Stock

Jan 10 2023	SELL Payment of exercise price or tax liability	$9,050 $3.03 p/Share	2,987 Reduced 2.12%	137,917 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	-	34,738 Added 19.78%	140,904 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$43 $0.01 p/Share	4,259 Added 3.86%	106,166 Common Stock
Jan 05 2021	BUY Exercise of conversion of derivative security	$16 $0.01 p/Share	1,604 Added 1.55%	101,907 Common Stock

Also insider at

CDAK

Codiak BioSciences, Inc. Healthcare

Director

ANP